Marketwise, Inc. (MKTW) Stock Price & Analysis
Marketwise, Inc. (MKTW) rose 2.09% to USD 17.11 as of June 10, 2026 at 10:01 UTC, according to Nexqual real-time market data.
MKTW last closed at USD 16.76; the session ranged USD 16.87–17.33 on volume of 31,072 shares. Market capitalization is $45.15M, with a 52-week range of USD 13.49–21.74 (NGM). Source: Nexqual, June 10, 2026 at 10:01 UTC.
Key Statistics (as of June 10, 2026 at 10:01 UTC)
| Price | USD 17.11 |
|---|---|
| Change | ▲ 2.09% (up) |
| Previous Close | USD 16.76 |
| Open | USD 16.96 |
| Day Range | USD 16.87 – 17.33 |
| 52-Week Range | USD 13.49 – 21.74 |
| Volume | 31,072 shares |
| Market Cap | $45.15M |
| Exchange | NGM |
Technical Analysis (MKTW)
Nexqual's technical model rates MKTW "STRONG SELL" based on 0 bullish and 5 bearish signals across 123 daily candles, as of June 10, 2026 at 10:01 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 46.88 (neutral) |
| vs SMA50 | Below (USD 17.44) |
| MACD | -0.16 (negative) |
Analyst Ratings (MKTW)
Wall Street analysts rate MKTW "None" based on 3 analysts, with a mean price target of USD 22.85 (range USD 20–24.54), per Nexqual as of June 10, 2026 at 10:01 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 3 |
| Mean Target | USD 22.85 |
| High Target | USD 24.54 |
| Low Target | USD 20 |
| Buy / Hold / Sell | 0 / 1 / 0 |
Earnings (MKTW)
| Revenue Estimate | $80.50M |
|---|
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD -0.23 vs est 0.67 ▼ miss |
| 2025-12-31 | USD 0.76 vs est -0.22 ▲ beat |
| 2025-09-30 | USD 0.58 vs est -1.32 ▲ beat |
| 2025-06-30 | USD 0.53 vs est 0.64 ▼ miss |
Source: Nexqual, June 10, 2026 at 10:01 UTC.
Financials & Fundamentals (MKTW)
| Total Revenue | $321.64M |
|---|---|
| Revenue Growth (YoY) | -7.80% |
| Gross Margin | +86.24% |
| Operating Margin | -1.55% |
| Profit Margin | +1.29% |
| Current Ratio | 0.49 |
| Total Cash | $52.67M |
| Total Debt | $5.71M |
| Free Cash Flow | $34.96M |
Source: Nexqual, June 10, 2026 at 10:01 UTC.
Financial Health Score (MKTW)
Nexqual rates Marketwise, Inc.'s overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 10:01 UTC.
| Growth | Critical — Revenue -20% YoY (annual), sharp decline |
|---|---|
| Profitability | Solid — Gross margin 86%, operating -2% |
| Balance Sheet | Mixed — $53M cash vs $6M debt, net cash position |
| Cash Flow | Solid — FCF $35M, 11% margin |
| Efficiency | Mixed — No data |
Ownership (MKTW)
| Insider Ownership | +22.76% |
|---|---|
| Institutional Ownership | +28.47% |
| Shares Outstanding | 2.64M |
| Float | 1.74M |
| Short % of Float | +1.87% |
Source: Nexqual, June 10, 2026 at 10:01 UTC.
Leadership (MKTW)
Marketwise, Inc. is led by David Eifrig Jr. (age 66), CEO & Director, per Nexqual as of June 10, 2026 at 10:01 UTC.
| CEO & Director | David Eifrig Jr. (age 66) |
|---|---|
| Founder & Director | Frank Porter Stansberry (age 52) |
| COO, CFO & Principal Accounting Officer | Erik Mickels (age 48) |
| MD, Copywriter & Director | Michael Alan Palmer (age 53) |
| Senior Vice President of Financial Planning & Analysis | Lee Harris |
Major Backers & Investors (MKTW)
Notable institutional backers of Marketwise, Inc. include Barclays Plc, Phraction Management LLC, Fidelity, according to Nexqual as of June 10, 2026 at 10:01 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Barclays Plc | 5.75% |
| Phraction Management LLC | 3.73% |
| Fidelity | 1.36% |
| Renaissance Technologies | 1.03% |
| Royce & Associates LP | 0.95% |
| ROYCE SMALL-CAP TRUST, INC.-Royce Small-Cap Trust, Inc | 0.95% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 7.39% |
| Vanguard Group | 5.21% |
| Geode Capital | 1.87% |
| State Street | 1.05% |
Source: Nexqual, June 10, 2026 at 10:01 UTC.
From Marketwise, Inc.'s Latest SEC 10-K Filing (filed 2026-03-06)
Key Strengths & Strategy (as disclosed to the SEC)
- We have developed screeners, monitors, portfolio management tools, and a set of proprietary indicators that produce a composite score to rank several thousand publicly traded companies in the United States.
- Using this data-driven and time-tested approach, we have developed proprietary practices for customer acquisition that we believe set us apart from other companies.
- This allows us to gather insights and feedback and helps us create new products and solutions.
- Our Growth Strategy We are committed to growing our business by deepening our relationship with existing customers and attracting new subscribers to our platform.
Partnerships
- We started in 1999 with the simple idea that, if we could publish intelligent, independent, insightful, and in-depth investment research and treat the subscriber the way we would want to be treated, then subscribers would renew their subscriptions and stay with us.
- Experienced analysts, with their own unique investment strategies and philosophies, lead our brands.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| TGLO | theglobe.com, inc. | USD 0.3 | ▼ 9.09% |
| SEEK | THEDIRECTORY.COM | USD 0 | ▲ 0% |
| MLTX | MoonLake Immunotherapeutics | USD 17.8 | ▼ 0.56% |
| INKT | MiNK Therapeutics, Inc. | USD 11.82 | ▼ 0.42% |
| CNET | ZW Data Action Technologies Inc | USD 0.75 | ▲ 11.19% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 10:01 UTC. This page is informational and not investment advice.